Innovative Angiography Systems Advancing Tumor Embolization Treatments Trend: A Crucial Influence on the Tumor Embolization Devices Market's Transformation in 2025

What Is the Expected Size and Growth Rate of the Tumor Embolization Devices Market?
In recent times, the market size for tumor embolization devices has experienced significant growth. Projected to increase from a size of $1493.6 billion in 2024 to $1600.57 billion in 2025, it boasts a compound annual growth rate (CAGR) of 7.2%. The growth observed during the historic period can be linked to factors such as minimally invasive procedures, advancements in technology, increased incidence of cancer, and an aging population.

In the upcoming years, the market size for tumor embolization devices is anticipated to experience significant growth. The market is projected to escalate to $2286.1 billion by 2029, with a compound annual growth rate (CAGR) of 9.3%. The growth in the predicted period can be attributed to factors like personalized medicine, combination therapies, image-guided embolization, telemedicine, and remote consultations. Key trends that might be observed in this period will include advancements in embolic agents, transarterial chemoembolization (tace), embolization for palliative care, and image-guided procedures.

What Factors Are Fueling Growth in the Tumor Embolization Devices Market?
The global upsurge in cancer diagnoses is expected to spur the growth of the tumor embolization devices market in the projected timeframe. As an example, Macmillan Cancer Support, the premier healthcare charitable institution in the UK, projected in October 2022 that cancer patients would surge upward to 3.5 million by 2025, then to 4 million by 2030, and eventually hit 5.3 million by 2040. Consequently, this global influx in cancer occurrences is forecasted to stimulate the demand for the tumor embolization market in the upcoming years.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp

Which Leading Companies Are Shaping the Growth of the Tumor Embolization Devices Market?
Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.

What Are the Major Trends Shaping the Tumor Embolization Devices Market?
Leading businesses in the tumor embolization devices market are focusing on product innovation, particularly angiography systems, to enhance the precision and effectiveness of cancer treatment methods. These angiography systems are unique imaging tools that enable visualization of the body's blood vessels and the evaluation of blood flow. For example, in June 2022, a healthcare company from Germany, Siemens Healthineers, unveiled their product called Artis Icono Ceiling. The Artis Icono Ceiling is a ceiling-mounted angiography system developed to increase the accuracy of tumor embolization procedures and other interventional methods. The device provides rapid 3D data collection, with the ability to take images at the patient's head within 2.5 seconds and side views in 4 seconds. This is advantageous as it reduces motion artifacts and lessens the use of contrast media. Furthermore, the Artis Icono Ceiling is constructed for multipurpose use, making it suitable for a variety of disciplines, including interventional radiology and cardiology.

What Are the Key Segments of the Tumor Embolization Devices Market?
The tumor embolization devices market covered in this report is segmented -

1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers

Subsegments:
1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres, Holmium-166 Microspheres
2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs), Microspheres (Polyvinyl Alcohol - PVA Particles), Gelatin Sponges, Liquid Embolic Agents (Onyx, Glue-Based Agents)

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Which Region Dominates the Tumor Embolization Devices Market?
North America was the largest region in the tumor embolization devices market in 2023. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Tumor Embolization Devices Global Market Report?

- Market Size Analysis: Analyze the Tumor Embolization Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Tumor Embolization Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Tumor Embolization Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Tumor Embolization Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3352

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.